Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cambridge, UK

- PMLiVE

GSK reveals plans for £400m R&D facility expansion in England

GSK has formally started the process of seeking a development partner for the expansion plans

- PMLiVE

eureKARE to use $60m financing to bolster next-generation European biotech companies

New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology

- PMLiVE

UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs

- PMLiVE

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Includes measures to help businesses disrupted by the pandemic

- PMLiVE

ReNeuron set for recovery after Woodford stake sale

Edison analyst says sale should help shares to stabilise

- PMLiVE

UK biotech funding falls 40% between 2018 and 2019

Drop attributed to global uncertainty and Neil Woodford scandal

- PMLiVE

UK immunology biotech MiroBio launches with $34m fundraising

Will develop therapeutic antibodies for autoimmune diseases

- PMLiVE

European biotech: a new generation of leaders emerges

Three companies that are on the rise in biotech

- PMLiVE

Building Europe’s next breakthrough biotechs

Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK

- PMLiVE

Novartis and J&J back latest €400m Medicxi biopharma fund

Growing appetite from European investors to back early-stage biotechs

- PMLiVE

Illumina sets up first ex-US accelerator site in Cambridge

Boost for UK's golden triangle biotech region

- PMLiVE

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Big boost for Belgian biotech, without a buy-out

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links